World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
34677
World Ranking
7719
National Ranking
4016

Overview

Terry L. Smith is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily spans the fields of Neuroscience and Medicine, with specific attention to Neurology, Cognitive Neuroscience, and Pharmacology.

The key topics addressed in Terry L. Smith's work include Neuroinflammation and Neurodegeneration Mechanisms, Sleep and Wakefulness Research, and Cannabis and Cannabinoid Research. These areas reflect a focus on understanding complex neurological processes and the pharmacological effects related to these domains.

Among their recent scholarly contributions is the paper titled Diacylglycerol Lipase-β Knockout Mice Display a Sex-Dependent Attenuation of Traumatic Brain Injury-Induced Mortality with No Impact on Memory or Other Functional Consequences, published in 2021 in the journal Cannabis and Cannabinoid Research.

  • Diacylglycerol Lipase-β Knockout Mice Display a Sex-Dependent Attenuation of Traumatic Brain Injury-Induced Mortality with No Impact on Memory or Other Functional Consequences (2021, Cannabis and Cannabinoid Research)

Terry L. Smith frequently collaborates with other researchers, with notable co-authors including Lesley D. Schurman, Giulia Donvito, Benjamin F. Cravatt, Jason Newton, and Sarah Spiegel.

  • Lesley D. Schurman
  • Giulia Donvito
  • Benjamin F. Cravatt
  • Jason Newton
  • Sarah Spiegel

The primary venues for their publications include Cannabis and Cannabinoid Research, reflecting a consistent research interest in the intersection of cannabinoid pharmacology and neuroscience.

  • Cannabis and Cannabinoid Research

Best Publications

  • A note on quantifying follow-up in studies of failure time

    Michael Schemper;Terry L. Smith

  • Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

    Aman U. Buzdar;Nuhad K. Ibrahim;Deborah Francis;Daniel J. Booser

  • Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    Henry M. Kuerer;Lisa A. Newman;Terry L. Smith;Fred C. Ames

  • Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

    P. A. Greenberg;G. N. Hortobagyi;T. L. Smith;L. D. Ziegler

  • Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    Hagop M Kantarjian;Susan O'Brien;Terry L. Smith;Jorge E Cortes

  • High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine

    Jorge E. Romaguera;Luis Fayad;Maria A. Rodriguez;Kristine R. Broglio

  • Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer

    Francisco J. Esteva;Vicente Valero;Daniel Booser;Laura T. Guerra

  • Is breast cancer survival improving

    Sharon H. Giordano;Aman U. Buzdar;Terry L. Smith;Shu Wan Kau

  • Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-α therapy

    Hagop M. Kantarjian;Terry L. Smith;Susan O'Brien;Miloslav Beran

  • Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

    Marjorie C. Green;Aman U. Buzdar;Terry Smith;Nuhad K. Ibrahim

  • Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.

    Shi Ming Tu;Randall E. Millikan;Bayabel Mengistu;Ebrahim S. Delpassand

  • Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers

    Xiaoyan Zhou;Ming Tan;Valerie Stone Hawthorne;Kristine S. Klos

  • Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

    Francesco Onida;Hagop M. Kantarjian;Terry L. Smith;Greg Ball

  • Early and delayed clinical cardiotoxicity of doxorubicin.

    Aman U. Buzdar;Connie Marcus;George R. Blumenschein;Terry L. Smith

  • Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue

    Robert M. Byers;Adel K. El-Naggar;Ya Yen Lee;Basharah Rao

  • Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients

    Hagop M. Kantarjian;Michael J. Keating;Moshe Talpaz;Ronald S. Walters

  • Integrated therapy for locally advanced bladder cancer : final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

    Randall Millikan;Colin Dinney;David Swanson;Paul Sweeney

  • Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.

    Hagop M. Kantarjian;Michael J. Keating;Ronald S. Walters;Terry L. Smith

  • Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast Cancer

    Aman U Buzdar;S. Eva Singletary;Richard L. Theriault;Daniel J Booser

  • Adenocarcinoma as an Independent Risk Factor for Disease Recurrence in Patients with Stage IB Cervical Carcinoma

    P.J. Eifel;T.W. Burke;M. Morris;T.L. Smith

Frequent Co-Authors

Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Aman U. Buzdar
Aman U. Buzdar The University of Texas MD Anderson Cancer Center
Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center
Michael J. Keating
Michael J. Keating The University of Texas MD Anderson Cancer Center
Emil J. Freireich
Emil J. Freireich The University of Texas MD Anderson Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine
Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
George R. Blumenschein
George R. Blumenschein The University of Texas MD Anderson Cancer Center
Aysegul A. Sahin
Aysegul A. Sahin The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a variety of rewarding online degrees and alternate healthcare career pathways. For those interested in healthcare administration, you might consider the top online mha programs that are cahme accredited. These programs equip students with vital leadership and management skills for hospital and healthcare system careers.

Nurses looking to advance their education may opt for an rn to bsn online without clinicals, making it easier to balance work and learning. For those aiming for the highest nursing qualifications, consider the accelerated dnp programs online to complete your Doctor of Nursing Practice degree faster.

Cost is also an important factor, and there are cheapest online dnp programs available for those seeking affordability without sacrificing quality. Choosing the right online healthcare degree offers flexibility and specialized paths to support long-term career goals across the medical field.

Best Scientists Citing Terry L. Smith